HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motonobu Nakamura Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

1/2018Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression.
1/2018[Daily Life Style and Psoriasis].
1/2018Resolvin E1 attenuates murine psoriatic dermatitis.
2/2017Treatment satisfaction, willingness to pay and quality of life in Japanese patients with psoriasis.
7/2014IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
5/2014Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motonobu Nakamura Research Topics

Disease

29Neoplasms (Cancer)
01/2024 - 01/2010
21Drug Eruptions (Drug Eruption)
07/2021 - 08/2009
19Carcinoma (Carcinomatosis)
05/2024 - 12/2017
19Prostatic Neoplasms (Prostate Cancer)
01/2024 - 08/2012
16Neoplasm Metastasis (Metastasis)
12/2023 - 01/2015
8Melanoma (Melanoma, Malignant)
02/2022 - 04/2010
7Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 08/2014
7Inflammation (Inflammations)
01/2022 - 07/2014
7Lymphatic Metastasis
06/2021 - 06/2010
7Hypertension (High Blood Pressure)
03/2017 - 01/2014
7Insulin Resistance
03/2017 - 05/2011
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 02/2011
6Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 05/2014
5Pain (Aches)
01/2024 - 01/2015
5Skin Diseases (Skin Disease)
01/2022 - 07/2009
5Alopecia Areata
01/2022 - 10/2002
4Disease Progression
05/2024 - 12/2017
4Skin Neoplasms (Skin Cancer)
11/2021 - 02/2011
4Dermatitis
01/2018 - 05/2012
4Contact Dermatitis (Eczema, Contact)
10/2015 - 08/2002
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2013 - 04/2011
3Obesity
01/2022 - 05/2021
3Atopic Dermatitis (Atopic Eczema)
11/2019 - 07/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2017 - 03/2015
3Erythema
12/2016 - 05/2008
3Pruritus (Itching)
07/2014 - 02/2011
3Urticaria (Hives)
01/2014 - 11/2010
3Necrosis
01/2012 - 07/2009
3Alopecia (Baldness)
12/2011 - 06/2005
2Urologic Neoplasms (Urological Cancer)
02/2024 - 10/2022
2Tuberculosis (Tuberculoses)
09/2023 - 02/2020
2Acute Kidney Injury (Acute Renal Failure)
10/2022 - 07/2012
2Diarrhea
02/2022 - 10/2013
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 02/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2022 - 10/2014
2Infections
11/2021 - 11/2016
2Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2021 - 05/2014
2Merkel Cell Carcinoma
05/2021 - 07/2013

Drug/Important Bio-Agent (IBA)

12PlatinumIBA
05/2024 - 02/2018
12pembrolizumabIBA
10/2023 - 01/2020
9NivolumabIBA
12/2022 - 01/2015
7Insulin (Novolin)FDA Link
03/2017 - 01/2010
6Immune Checkpoint InhibitorsIBA
02/2024 - 11/2020
6Therapeutic UsesIBA
12/2023 - 06/2005
6Prostate-Specific Antigen (Semenogelase)IBA
01/2023 - 11/2014
6cabazitaxelFDA Link
06/2021 - 01/2019
6CytokinesIBA
05/2021 - 03/2008
6SodiumIBA
03/2017 - 01/2015
5Prednisolone (Predate)FDA LinkGeneric
02/2022 - 12/2011
4Radium-223IBA
01/2024 - 04/2020
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 03/2015
4IpilimumabIBA
12/2022 - 12/2019
4Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2021
4Proteins (Proteins, Gene)FDA Link
07/2021 - 03/2012
4Paclitaxel (Taxol)FDA LinkGeneric
05/2021 - 06/2017
4Cisplatin (Platino)FDA LinkGeneric
04/2020 - 03/2009
4InterleukinsIBA
01/2018 - 07/2010
4Anti-Bacterial Agents (Antibiotics)IBA
11/2016 - 07/2009
4Cytidine DeaminaseIBA
04/2016 - 09/2011
4Cholinergic Agents (Cholinergics)IBA
07/2014 - 11/2010
3avelumabIBA
05/2024 - 12/2023
3Docetaxel (Taxotere)FDA Link
04/2022 - 02/2019
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2022 - 01/2020
3InterferonsIBA
11/2021 - 04/2016
3Cell Adhesion Molecule-1IBA
05/2021 - 01/2018
3Carboplatin (JM8)FDA LinkGeneric
05/2021 - 12/2017
3secukinumabIBA
08/2018 - 02/2017
3Interleukin-23 (Interleukin 23)IBA
01/2018 - 07/2014
3Imiquimod (Aldara)FDA LinkGeneric
01/2018 - 07/2014
3DNA (Deoxyribonucleic Acid)IBA
12/2016 - 05/2012
3tocilizumab (atlizumab)FDA Link
10/2016 - 05/2009
3ThiazolidinedionesIBA
05/2015 - 05/2011
3Interleukin-17 (Interleukin 17)IBA
07/2014 - 01/2011
3Interferon-gamma (Interferon, gamma)IBA
12/2011 - 03/2008
3Interleukin-4 (Interleukin 4)IBA
12/2011 - 03/2008
2SteroidsIBA
09/2023 - 12/2011
2Alkaline PhosphataseIBA
01/2023 - 01/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2023 - 01/2020
2Glutens (Glutelin)IBA
01/2022 - 05/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 08/2021
2Adalimumab (Humira)FDA Link
01/2022 - 02/2017
2Tyrosine Kinase InhibitorsIBA
01/2022 - 02/2017
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 02/2017
2CreatinineIBA
01/2022 - 07/2013
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2021 - 01/2018
2Cell Adhesion MoleculesIBA
11/2021 - 05/2021
2Histamine (Histamine Dihydrochloride)FDA Link
08/2021 - 02/2011
2LigandsIBA
07/2021 - 04/2010
2Antimicrobial PeptidesIBA
06/2021 - 07/2012

Therapy/Procedure

26Therapeutics
05/2024 - 10/2002
23Drug Therapy (Chemotherapy)
05/2024 - 08/2012
11Castration
01/2024 - 01/2019
9Prostatectomy (Retropubic Prostatectomy)
02/2020 - 06/2002
7Radiotherapy
01/2022 - 06/2010
3Renal Dialysis (Hemodialysis)
09/2023 - 11/2016
3Immunotherapy
11/2021 - 10/2002
2Aftercare (After-Treatment)
01/2024 - 07/2009
2Nephrectomy
01/2022 - 09/2017
2Intravenous Administration
11/2021 - 01/2015